Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$763M |
| 2 |
Amazon
AMZN
|
+$688M |
| 3 |
TSMC
TSM
|
+$562M |
| 4 |
Tesla
TSLA
|
+$419M |
| 5 |
Johnson & Johnson
JNJ
|
+$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
Novo Nordisk
NVO
|
+$366M |
| 4 |
JPMorgan Chase
JPM
|
+$335M |
| 5 |
ASML
ASML
|
+$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Griffon
GFF
$3.61B
| $4.17M | 0.01% |
116,400
-26,200
| -18% | -$938K |
|
1627
Southern First Bancshares
SFST
$366M
| $4.16M | 0.01% |
90,902
-6,305
| -6% | -$288K |
|
1628
PRA Group
PRAA
$657M
| $4.14M | 0.01% |
122,511
+4,100
| +3% | +$138K |
|
1629
FNB Corp
FNB
$5.89B
| $4.13M | 0.01% |
316,300
+60,700
| +24% | +$792K |
|
1630
iShares Russell 1000 Value ETF
IWD
$63.8B
| $4.13M | 0.01% |
27,200
+22,900
| +533% | +$3.47M |
|
|
VIA
1631
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $4.12M | 0.01% |
161,330
-14,060
| -8% | -$359K |
|
1632
BJ's Restaurants
BJRI
$684M
| $4.12M | 0.01% |
156,229
+84,900
| +119% | +$2.24M |
|
1633
PIMCO Active Bond Exchange-Traded Fund
BOND
$5.88B
| $4.12M | 0.01% |
+45,500
| New | +$4.12M |
|
1634
Leslie's
LESL
$62M
| $4.11M | 0.01% |
+336,400
| New | +$4.11M |
|
|
TEN
1635
Tsakos Energy Navigation Ltd.
TEN
$672M
| $4.11M | 0.01% |
242,580
+32,300
| +15% | +$547K |
|
|
NXGN
1636
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.11M | 0.01% |
218,676
+52,976
| +32% | +$995K |
|
1637
Consumer Portfolio Services
CPSS
$190M
| $4.1M | 0.01% |
462,758
-58,900
| -11% | -$521K |
|
1638
Clover Health Investments
CLOV
$1.57B
| $4.09M | 0.01% |
4,402,400
+421,700
| +11% | +$392K |
|
|
SPNE
1639
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $4.09M | 0.01% |
489,500
-53,200
| -10% | -$444K |
|
1640
B. Riley Financial
RILY
$190M
| $4.08M | 0.01% |
119,139
+81,500
| +217% | +$2.79M |
|
1641
iShares MBS ETF
MBB
$41.5B
| $4.07M | 0.01% |
+43,900
| New | +$4.07M |
|
1642
Gencor Industries
GENC
$224M
| $4.07M | 0.01% |
402,840
-20,800
| -5% | -$210K |
|
|
CSTR
1643
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $4.05M | 0.01% |
229,499
-25,500
| -10% | -$450K |
|
1644
Cambium Networks
CMBM
$20.4M
| $4.03M | 0.01% |
185,900
-4,400
| -2% | -$95.3K |
|
|
CHMI
1645
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $4.03M | 0.01% |
693,884
-61,700
| -8% | -$358K |
|
|
ENZ
1646
DELISTED
Enzo Biochem, Inc.
ENZ
| $4.02M | 0.01% |
2,813,964
-95,700
| -3% | -$137K |
|
1647
Xponential Fitness
XPOF
$313M
| $4.02M | 0.01% |
175,300
+87,400
| +99% | +$2M |
|
1648
Iron Mountain
IRM
$28.6B
| $4.02M | 0.01% |
80,600
-53,900
| -40% | -$2.69M |
|
1649
German American Bancorp
GABC
$1.53B
| $4.02M | 0.01% |
107,648
+12,249
| +13% | +$457K |
|
1650
Inovio Pharmaceuticals
INO
$126M
| $4.01M | 0.01% |
214,375
+20,733
| +11% | +$388K |
|